Lawmakers sent Gov. Ron DeSantis HB 843, a bill that would strike a blow against health care monopolies and enact several health care reforms, but none as important to me as the language eliminating many of these burdensome non-compete clauses. With a stroke of his pen, our governor can end practices that restrict patients from seeing the physicians they choose, writes Steve Dozier, who is…
Learn more about how prostate cancer is detected, risk factors, and treatments on our full video. Watch the full video on prostate cancer by clicking…
Aventa Genomics has launched its next-generation sequencing (NGS) test, Aventa FusionPlus, to identify gene fusions and translocations.
Aventa Genomics, a joint venture of Arima Genomics and Protean BioDiagnostics, launched the Aventa FusionPlus test for patients with solid cancers.
Aventa Genomics has launched its next-generation sequencing (NGS) test, Aventa FusionPlus, to identify gene fusions and translocations.
Cannabis is widely used by patients with cancer to help with cancer symptoms and treatment side effects. Though cannabis has immunomodulatory effects, and its consumption…
/PRNewswire-PRWeb/ — Protean BioDiagnostics is proud to announce its partnership with Travera. As one of Travera’s first Center of Excellence, the partnership…
Protean’s new partnership with Travera will bring expanded treatment options to advanced carcinoma patients and their physicians.
ChromaCode has entered into a partnership with Protean BioDiagnostic for the launch of a non-small cell lung cancer (NSCLC) assay in the US.
Protean is excited to partner with ChromaCode, Inc., to bring innovative cancer diagnostic technologies to oncologists and patients!
